New hope for tough UC cases: experimental drug ATH-063 enters Mid-Stage trial
Disease control
Not yet recruiting
This study tests an experimental drug called ATH-063 for people with moderate to severe ulcerative colitis (UC) who have not responded to other advanced treatments. About 120 adults will receive either the drug or a placebo to see if it can reduce symptoms like diarrhea and bleed…
Phase: PHASE2 • Sponsor: Athos Therapeutics Inc • Aim: Disease control
Last updated May 04, 2026 03:19 UTC